Johnson & Johnson reports $100 million in quarterly sales from Covid vaccine
April 20, 2021 at 06:49 AM EDT
J&J's financial results come as the company's Covid-19 vaccine has been put on pause in the United States.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|